Integrated Health Systems is seeking volunteers with mild to moderate Alzheimer’s for a groundbreaking study using a telomerase induction therapy. Applicants will need to have already been diagnosed to qualify and will need to send their medical records to IHS before scheduling a complimentary consultation appointment.

Qualifications for Study Admission (Inclusion Criteria):

  • Probable Alzheimer’s Disease based on the diagnosis criteria of NIA-AA guideline (the U.S. National Institute on Aging and Alzheimer’s Association guideline, McKhann et al, 2011 from your neurologist’s evaluation; Male or female, 50 years and older;
  • All patients recruited into this study must meet MMSE score ≤24 points, patients with MMSE score as 21-24 points will be enrolled into mild group, patients with MMSE score as 10-20 points will be enrolled into moderate group;
  • Must provide current PET or MRI Scan of your brain and agree to provide follow-up scans and neurological evaluations;
  • Have a reliable caregiver who can accompany the patient to the site at patient’s expense to complete the required study procedures; Provide the informed consent.

Exclusion Criteria:

  • Patients with severe aphasia or physical disability who were unable to complete neuropsychological examination;
  • Patients with mental illness;
  • Patients with a history of alcoholism and drug addiction, or traumatic brain injury, epilepsy, encephalitis, normal-pressure hydrocephalus and other neurological disorders causing cognitive impairment;
  • Patients with systemic diseases causing dementia (e.g. liver and kidney insufficiency, endocrine disorders, vitamin deficiency);
    Subjects who are unwilling or unable to abide by the study requirement.

At this point an Alzheimer’s cure looks remote. Decades of work by pharmaceutical companies has yielded very disappointing results and, at this time, there are no effective ways to manage, much less reverse, its progression. Alzheimer’s prevention is a growing area of interest, with promises of a vaccine coming in the near future. However, as the researchers behind the vaccine have warned, it has only passed muster with mice, meaning approval for humans is years away. In the meantime nearly 800 diagnoses are made every day.  Some common Alzheimer’s symptoms include:

  • Repeating statements or questions
  • Forgetting conversations and events
  • Regularly misplacing things, especially in placing them in unusual places
  • Difficulty navigating familiar routes, getting lost in familiar places
  • Having trouble finding the right words to articulate a thought or describe an object

There are some lifestyle adjustments that can be made to reduce your risk, but the single largest Alzheimer’s risk factor is aging. Telomere shortening is one of the major hallmarks of aging, one of the processes that causes the functioning of your cells and, ultimately, your brain and body, to decline over time. This is what makes Integrated Health System’s telomerase induction gene therapy a potential game changer in the treatment of neurodegenerative diseases.

If you or a loved one are interested in receiving a free $62,000 therapy, please fill out the form below

Latest posts by ihs webadmin (see all)

Three steps to a healthy you



Consult With
A Doctor